<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562717</url>
  </required_header>
  <id_info>
    <org_study_id>0028022</org_study_id>
    <secondary_id>2011-004497-28</secondary_id>
    <nct_id>NCT01562717</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries</brief_title>
  <official_title>A Randomised, Multicentre, Two-arm, Parallel Group, Double-blind, Placebo-controlled, Comparative Efficacy and Safety Clinical Study of Ibuprofen in Patients With Pain Related to Uncomplicated Ankle Injuries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orion Corporation, Orion Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orion Corporation, Orion Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate the efficacy and safety of Ibuprofen in patients
      with ankle injuries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to evaluate the efficacy and safety of Ibuprofen versus placebo
      in patients for the treatment of pain related to uncomplicated ankle injuries.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy: VAS</measure>
    <time_frame>Day 7</time_frame>
    <description>VAS pain score change over time from baseline to day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy: VAS</measure>
    <time_frame>Day 3 and Day 7</time_frame>
    <description>Percentage VAS pain score change from baseline separately to day 3 and 7</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>3 times a day</description>
    <arm_group_label>Ibuprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>3 times a day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent obtained.

          2. Male and female patients, age in the range of 18-45 years (inclusive).

          3. Patients with pain related to uncomplicated ankle injuries (in case of doubt whether
             it is complicated an X-ray should be taken).

          4. Pain related to ankle injuries is scored as moderate or severe by the patient and the
             injury is less than 24 hours old.

          5. Patients with normal or clinically non-significant findings as determined by baseline
             history, physical examination and vital signs (blood pressure, heart rate and axillary
             temperature).

          6. Comprehension of the nature and purpose of the study and compliance with the protocol
             requirements.

          7. Negative urine pregnancy test (for females only).

        Exclusion Criteria:

          1. Known hypersensitivity to aspirin or any non-steroidal anti-inflammatory drugs
             (NSAID).

          2. Known history of asthma.

          3. Known history of gastric or peptic ulcer or bleeding.

          4. Known history of malignancy or other serious diseases.

          5. Known history of skin allergy.

          6. Known history of cardiac, renal or hepatic insufficiency.

          7. Presence of bruises or rash on the skin of ankle.

          8. Presence of skin lesions like eczema or psoriasis.

          9. Arthritis in the same joint.

         10. Alcohol use during the study period or within 48 hours before the study enrolment.

         11. Patients judged unable to use the VAS for pain reliably

         12. Locally applied NSAID to the painful region/area of study or oral use of NSAID or
             other analgesics 48 hours before the study enrolment.

         13. Other pain killers than rescue medication to be taken during the study.

         14. Recurrent sprain at the same joint during the last 6 months.

         15. Anticoagulant therapy.

         16. Physiotherapy during study period.

         17. Open wounds, infected skin or fracture.

         18. Any other condition that in the opinion of the investigator would interfere with the
             evaluation of the results or constitute a health risk for the patient.

         19. Pregnant or lactating females.

         20. Participation in a drug or device study within 90 days before the study enrolment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juha-Pekka Kaukonen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Terveystalo Lahti</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Terveystalo Lahti</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2012</study_first_posted>
  <last_update_submitted>May 7, 2013</last_update_submitted>
  <last_update_submitted_qc>May 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ankle Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

